The "Primer on Cancer Immunology and Immunotherapy," hosted by Gustave Roussy and SOCRATE, in collaboration with the Society for Immunotherapy of Cancer, was presented at the International Conference on Immunotherapy Radiotherapy Combinations on September 20, 2018.Program SummaryOver 420 attendees from 4 continents, 35 scientific presentations, 60 posters, and almost 200 participants for the gala dinner cruise: this event was the cornerstone of immunotherapy/radiotherapy combination approaches. The mixed audience of this conference led to incredibly rich exchanges and networking. People from industry to academia, from life science to the clinic, from immunology to radiobiology, connected to discuss the most recent therapeutical targets and innovative clinical trials.Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, scroll down to view Related Entries and Links.#Biomarkers#ImmuneResponsiveness#GastrointestinalCancers#Lymphoma#Melanoma#NonSmallCellLungCancer#RenalCellCarcinoma#PresentationSlides#CollaborativeEvent#AdverseEvents#Toxicities#AdoptiveCellTherapy#CombinationTherapy#Cytokines#ImmuneCheckpointInhibitors#Immunomodulators#TherapeuticAntibodies#Vaccines#Clinician#RegisteredNurse#Oncologist#Pharmacist#2018SITC Cancer Immunotherapy Guidelines https://www.sitcancer.org/research/cancer-immunotherapy-guidelinesJournal for ImmunoTherapy of Cancer https://jitc.biomedcentral.com/articles Patient Resource Guides https://www.sitcancer.org/connectedold/patient
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us